1. Home
  2. ENTA vs TLS Comparison

ENTA vs TLS Comparison

Compare ENTA & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.50

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$4.18

Market Cap

317.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
TLS
Founded
1995
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
317.1M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
ENTA
TLS
Price
$12.50
$4.18
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$20.40
$7.90
AVG Volume (30 Days)
143.3K
967.8K
Earning Date
05-11-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
29.93
31.51
EPS
N/A
N/A
Revenue
$102,814,000.00
$164,805,000.00
Revenue This Year
$7.76
$18.72
Revenue Next Year
N/A
$14.62
P/E Ratio
N/A
N/A
Revenue Growth
16.48
52.21
52 Week Low
$4.09
$1.83
52 Week High
$17.15
$8.36

Technical Indicators

Market Signals
Indicator
ENTA
TLS
Relative Strength Index (RSI) 44.54 45.69
Support Level $12.09 $3.80
Resistance Level $15.52 $4.73
Average True Range (ATR) 0.78 0.34
MACD -0.07 0.02
Stochastic Oscillator 36.00 25.31

Price Performance

Historical Comparison
ENTA
TLS

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: